VM Voyageur Pharmaceuticals Ltd.

TSXV · CA · Healthcare · Drug Manufacturers - Specialty & Generic · voyageurpharmaceuticals.ca

0.1400CAD+3.70%Mkt Cap: 18.30M $P/E: —3d ago

Voyageur Pharmaceuticals Ltd., together with its subsidiaries, engages in acquiring, exploring, and developing raw materials for pharmaceutical products in the United States of America, the province of British Columbia, …

Industry Peers

Drug Manufacturers - Specialty & Generic

Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)

$57.06BUSD

TEVA

Teva Pharmaceutical Industries Limited Ordinary Shares

$46.10BUSDP/E 65.9

HLN

Haleon plc American Depositary Shares (Each representing two Ordinary Shares)

Zoetis Inc. Class A Common Stock

$28.80BUSDP/E 11.4

UTHR

United Therapeutics Corporation - Common Stock

$23.23BUSDP/E 19.4

VTRS

Viatris Inc. - Common Stock

$20.22BUSD

SOBI

Swedish Orphan Biovitrum AB (publ)

$14.14BUSDP/E 110.6

NBIX

Neurocrine Biosciences, Inc. - Common Stock

Elanco Animal Health Incorporated Common Stock

$11.06BUSD

RDY

Dr. Reddy's Laboratories Ltd Common Stock

Amneal Pharmaceuticals, Inc. - Class A Common Stock

$7.07BUSDP/E 42.3

ALKS

Alkermes plc - Ordinary Shares

$7.00BUSDP/E 109.9

HIMS

Hims & Hers Health, Inc. Class A Common Stock

$6.77BUSD

LNTH

Lantheus Holdings, Inc. - Common Stock

$6.53BUSDP/E 23.9

KNSA

Kiniksa Pharmaceuticals International, plc - Class A Ordinary Shares

$5.83BUSDP/E 76.6

INDV

Indivior Pharmaceuticals, Inc. - Common Stock

$4.21BUSDP/E 12.8

Key Statistics

Company

Market Cap18.30M USD

Enterprise Value22.78M USD

Revenue (TTM)34.40K USD

Gross Profit0 USD

Net Income (TTM)-2.57M USD

Revenue/Share0.00 CAD

Last Price0.1400 CAD

Fiscal Year EndNov 2025

MR QuarterMay 2026

Employees—

CountryCA

SectorHealthcare

IndustryDrug Manufacturers - Specialty & Generic

ISIN—

Valuation

P/E (Trailing)—

P/E (Forward)—

PEG—

EV/EBITDA-9.49

EV/Revenue662.26

P/S531.90

P/B35.00

EPS (TTM)-0.02

EPS (Forward)—

52W Range

0.070056% of range0.1950

52W High0.1950 CAD

52W Low0.0700 CAD

Profitability

Gross Margin0.00%

Oper. Margin-5312.69%

EBITDA Margin0.00%

Profit Margin-30231.56%

ROE-282.05%

ROA-113.77%

Growth

Revenue Growth—

Earnings Growth—

Cash Flow & Leverage

Operating CF-2.11M USD

CapEx (TTM)—

FCF Margin-811.73%

FCF Yield-1.53%

Net Debt-293.80K USD

Net Debt/EBITDA0.12

Balance Sheet

Debt/Equity0.03

Current Ratio0.23

Quick Ratio0.18

Book Value/Sh0.0040 CAD

Cash/Share0.0020 CAD

Dividends

Fwd Div Rate—

Trail. Div Rate0.00 CAD

Div. Yield0.00%

5Y Avg Yield—

Payout Ratio0.00%

Ex-Div Date—

Pay DateMar 7, 2017

Splits

Last Split1:2

Split DateMar 7, 2017

Analyst Consensus

Rating—

Target (Mean)—

Target Range—

# Analysts—

Ownership

Shares Out.179.48M

Float209.24M

Insiders6.93%

Institutions0.00%

Short Interest

Short Ratio0.0d

Short % Out.0.00%

Shares Short3.09K

Short (prev mo.)20.57K

Technical

SMA 500.1551 (-9.7%)

SMA 2000.1378 (+1.6%)

Beta0.36

S&P 52W Chg14.58%

Avg Vol (30d)155.66K

Avg Vol (10d)95.75K

Technical Indicators

RSI (14)41.8

MACD-0.0045

MACD Signal-0.0010

MACD Hist.-0.0035

BB Upper0.1801 CAD

BB Middle0.1550 CAD

BB Lower0.1299 CAD

BB Width32.43%

ATR (14)0.0082 CAD

Vol Ratio (20d)1.00x